1. Home
  2. EVAX vs XWEL Comparison

EVAX vs XWEL Comparison

Compare EVAX & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evaxion Biotech

EVAX

Evaxion Biotech

HOLD

Current Price

$3.10

Market Cap

29.7M

Sector

Health Care

ML Signal

HOLD

XWEL

XWELL Inc.

HOLD

Current Price

$0.95

Market Cap

9.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVAX
XWEL
Founded
2008
2006
Country
Denmark
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
29.7M
9.2M
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
EVAX
XWEL
Price
$3.10
$0.95
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$11.67
N/A
AVG Volume (30 Days)
229.8K
32.2K
Earning Date
05-07-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$29,210,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$328.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.77
$0.26
52 Week High
$12.15
$2.20

Technical Indicators

Market Signals
Indicator
EVAX
XWEL
Relative Strength Index (RSI) 49.98 44.09
Support Level $2.91 $0.88
Resistance Level $3.62 $1.15
Average True Range (ATR) 0.15 0.05
MACD 0.00 -0.00
Stochastic Oscillator 35.38 8.95

Price Performance

Historical Comparison
EVAX
XWEL

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

About XWEL XWELL Inc.

XWELL Inc is an international wellness organization dedicated to delivering restorative and health-focused services to travelers through its three reportable operating segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment, which generates maximum revenue, operates spa service locations in airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program. The Naples Wax Center segment operates six locations offering face and body waxing, skincare services, and cosmetic products. The Company generates maximum revenue from the United States.

Share on Social Networks: